Xylem Inc. (XYL)

Basic

  • Market Cap

    $25.6B

  • EV

    $27.28B

  • Shares Out

    241.08M

  • Revenue

    $6,752M

  • Employees

    17,800

Margins

  • Gross

    37.59%

  • EBITDA

    16.57%

  • Operating

    11.26%

  • Pre-Tax

    9.09%

  • Net

    7.29%

  • FCF

    7.51%

Returns (5Yr Avg)

  • ROA

    4.96%

  • ROE

    13.51%

  • ROCE

    9.8%

  • ROIC

    9.17%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    $117.57

  • P/E

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

Per Share

  • Rev

    $33.47

  • Earnings (Dil)

    $2.42

  • FCF

    $2.5

  • Book Value

    $41.24

Growth (CAGR)

  • Rev 3Yr

    11.48%

  • Rev 5Yr

    5.78%

  • Rev 10Yr

    5.99%

  • Dil EPS 3Yr

    25.28%

  • Dil EPS 5Yr

    2.11%

  • Dil EPS 10Yr

    6.83%

  • Rev Fwd 2Yr

    23.32%

  • EBITDA Fwd 2Yr

    35.37%

  • EPS Fwd 2Yr

    19.43%

  • EPS LT Growth Est

    14.15%

Dividends

  • Yield

    —

  • Payout

    52.9%

  • DPS

    $1.29

  • DPS Growth 3Yr

    8.14%

  • DPS Growth 5Yr

    9.75%

  • DPS Growth 10Yr

    11.1%

  • DPS Growth Fwd 2Yr

    9.18%

Select a metric from the list below to chart it

Dec '13
Dec '15
Dec '17
Dec '19
Dec '21
LTM
Metric
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
LTM

Total Revenues

5,207.0

5,249.0

4,876.0

5,195.0

5,522.0

6,752.0

Total Revenues % Chg.

10.6%

0.8%

-7.1%

6.5%

6.3%

26.5%

Cost of Goods Sold, Total

3,181.0

3,203.0

3,046.0

3,216.0

3,434.0

4,214.0

Gross Profit

2,026.0

2,046.0

1,830.0

1,979.0

2,088.0

2,538.0

Selling General & Admin Expenses, Total

1,150.0

1,165.0

1,158.0

1,193.0

1,237.0

1,552.0

R&D Expenses

189.0

191.0

187.0

204.0

206.0

226.0

Other Operating Expenses, Total

1,339.0

1,356.0

1,345.0

1,397.0

1,443.0

1,778.0

Operating Income

687.0

690.0

485.0

582.0

645.0

760.0

Interest Expense, Total

-82.0

-67.0

-77.0

-76.0

-50.0

-48.0

Interest And Investment Income

4.0

5.0

7.0

7.0

16.0

16.0

Net Interest Expenses

-78.0

-62.0

-70.0

-69.0

-34.0

-32.0

Income (Loss) On Equity Invest.

5.0

3.0

2.0

9.0

—

—

Other Non Operating Income (Expenses)

-3.0

-5.0

1.0

-2.0

1.0

10.0

EBT, Excl. Unusual Items

611.0

626.0

418.0

520.0

612.0

738.0

Restructuring Charges

-20.0

-53.0

-54.0

-10.0

-19.0

-64.0

Merger & Related Restructuring Charges

-4.0

—

—

—

—

-56.0

Impairment of Goodwill

—

-148.0

-58.0

—

—

—

Gain (Loss) On Sale Of Assets

—

1.0

—

2.0

1.0

—

Asset Writedown

-2.0

-10.0

-21.0

-1.0

-14.0

-4.0

Other Unusual Items

—

—

—

—

-140.0

—

EBT, Incl. Unusual Items

585.0

416.0

285.0

511.0

440.0

614.0

Income Tax Expense

36.0

15.0

31.0

84.0

85.0

122.0

Earnings From Continuing Operations

549.0

401.0

254.0

427.0

355.0

492.0

Minority Interest

—

—

—

—

—

—

Net Income

549.0

401.0

254.0

427.0

355.0

492.0

Net Income to Common Incl Extra Items

549.0

401.0

254.0

427.0

355.0

492.0

Net Income to Common Excl. Extra Items

549.0

401.0

254.0

427.0

355.0

492.0

Total Shares Outstanding

179.7

180.1

180.4

180.4

180.3

240.8

Weighted Avg. Shares Outstanding

179.8

180.0

180.1

180.2

180.2

201.8

Weighted Avg. Shares Outstanding Dil

181.1

181.2

181.1

181.5

181.0

202.9

EPS

3.1

2.2

1.4

2.4

2.0

2.4

EPS Diluted

3.0

2.2

1.4

2.4

2.0

2.4

EBITDA

948.0

947.0

736.0

827.0

881.0

1,119.0